Cargando…

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool

The World Health Organization’s Model List of Essential Medicines for Children (EMLc) presents a list of the most efficacious, safe, and cost-effective medicines for priority conditions, intended for use in children up to 12 years of age. However, gaps in global availability and use of age-appropria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walsh, Jennifer, Masini, Tiziana, Huttner, Benedikt D., Moja, Lorenzo, Penazzato, Martina, Cappello, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950931/ https://www.ncbi.nlm.nih.gov/pubmed/35335850 http://dx.doi.org/10.3390/pharmaceutics14030473

Ejemplares similares

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project
por: Barbieri, Elisa, et al.
Publicado: (2023)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance
por: Zanichelli, Veronica, et al.
Publicado: (2023)

How to improve antibiotic awareness campaigns: findings of a WHO global survey
por: Huttner, Benedikt, et al.
Publicado: (2019)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Tough decisions on essential medicines in 2015
por: Magrini, Nicola, et al.
Publicado: (2015)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Administration of paediatric intranasal sedation: Need for appropriate formulation & equipment for dispensation
por: Parida, Satyen, et al.
Publicado: (2023)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
por: delMoral-Sanchez, Jose-Manuel, et al.
Publicado: (2020)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

HIV misdiagnosis in paediatrics: unpacking the complexity
por: Sacks, Emma, et al.
Publicado: (2017)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Huttner, Benedikt, et al.
Publicado: (2020)

Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains
por: van der Vossen, Anna, et al.
Publicado: (2021)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
por: Rowlands, Amanda, et al.
Publicado: (2016)

Estimating future trends in paediatric HIV
por: Penazzato, Martina, et al.
Publicado: (2014)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

The WHO list of essential in vitro diagnostics: Development and next steps
por: Moussy, Francis Gabriel, et al.
Publicado: (2018)

Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use
por: Khan, Dilawar, et al.
Publicado: (2023)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Effective coding is key to the development and use of the WHO Essential Diagnostics List
por: McKnight, Jacob, et al.
Publicado: (2019)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Shortening the decade‐long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low‐ and middle‐income countries
por: Penazzato, Martina, et al.
Publicado: (2018)

Endocrinology and the essential list
por: Kalra, Sanjay, et al.
Publicado: (2012)

COVID-19 and MIS-C treatment in children—results from an international survey
por: Donà, Daniele, et al.
Publicado: (2023)

Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly
por: Kuhn-Thiel, Alexandra M., et al.
Publicado: (2013)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Paediatric Formulation: Design and Development
por: Lopalco, Antonio, et al.
Publicado: (2020)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

THE ESSENTIALS OF PÆDIATRICS FOR NURSES
Publicado: (1957)

Essential Paediatric Dermatology
por: Burton, J. L.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_lfdhr4vqebfk96fk4e8s1542ru